Home Cart Sign in  
Chemical Structure| 1360614-48-7 Chemical Structure| 1360614-48-7

Structure of Necrosulfonamide
CAS No.: 1360614-48-7

Chemical Structure| 1360614-48-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Necrosulfonamide is a necroptosis inhibitor that selectively targets the mixed lineage kinase domain-like protein (MLKL), preventing the MLKL-RIP1-RIP3 necrosome complex from interacting with its downstream effectors. MLKL is a critical substrate of RIP3 during necrosis induction.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Necrosulfonamide

CAS No. :1360614-48-7
Formula : C18H15N5O6S2
M.W : 461.47
SMILES Code : O=C(NC1=CC=C(S(=O)(NC2=NC=CN=C2OC)=O)C=C1)/C=C/C3=CC=C([N+]([O-])=O)S3
MDL No. :MFCD02370191
InChI Key :FNPPHVLYVGMZMZ-XBXARRHUSA-N
Pubchem ID :1566236

Safety of Necrosulfonamide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • MLKL

In Vitro:

Cell Line
Concentration Treated Time Description References
B16 melanoma cells 1 μM 24 h To evaluate the effect of NSA on cell death, results showed that NSA did not inhibit cell death induced by erastin or RSL3 PMC10623471
RAW264.7 cells 10 μM 4 h To detect cell death in the necroptosis pathway, results showed that the NSA inhibitor could partially reduce PrsA-induced cell death PMC10467536
Bel-7402 and SMMC-7721 cells 1 µM Inhibition of necroptosis PMC8052337
human monocytes 5 µM 3, 6, 12, 24 hpi Inhibits pMLKL membrane translocation, prevents H7N9-induced monocyte cell death PMC6549191
Caco-2 cells 1 µM 1 h Treatment with necrosulfonamide resulted in a decrease in SpvB-mediated cell death, indicating that SpvB promotes necroptosis through MLKL phosphorylation. PMC8810775
primary MEF cells 5 µM NSA 24 h NSA exhibited neuroprotective effects against 6-OHDA plus TNF-α-induced cell death PMC10693130
primary neuronal cells 5 µM NSA 14 days NSA markedly reduced PFFs-induced neuronal cell death PMC10693130
mPDAC cells 1 μM 24 h To evaluate the effect of Necrosulfonamide on ferroptosis, results showed that Necrosulfonamide had no significant effect on ferroptosis PMC7843652

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Myocardial ischemia-reperfusion injury model Intraperitoneal injection 20 mg/kg Once daily for 3 weeks NSA treatment significantly reduced plasma cTnT, CK-MB, and LDH content in KO mice with I/R injury, suggesting ameliorated cardiac damage. PMC11550357
mice PANC1 or MIAPaCa2 xenograft models intraperitoneal injection 10 mg/kg once every other day for 2 weeks To evaluate the effect of Necrosulfonamide on the anticancer activity induced by ferroptosis, results showed that Necrosulfonamide had no significant effect on ferroptosis PMC7843652

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.83mL

2.17mL

1.08mL

21.67mL

4.33mL

2.17mL

References

 

Historical Records

Categories